Fort Washington Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Hold
1,300
﹤0.01% 381
2026
Q1
$224K Hold
1,300
﹤0.01% 400
2025
Q4
$259K Hold
1,300
﹤0.01% 388
2025
Q3
$203K Buy
+1,300
New +$206K ﹤0.01% 410
2025
Q1
Sell
-1,300
Closed -$240K 398
2024
Q4
$240K Hold
1,300
﹤0.01% 382
2024
Q3
$256K Hold
1,300
﹤0.01% 379
2024
Q2
$269K Buy
1,300
+380
+41% +$86.1K ﹤0.01% 376
2024
Q1
$249K Buy
920
+20
+2% +$4.78K ﹤0.01% 381
2023
Q4
$213K Buy
+900
New +$177K ﹤0.01% 384
2022
Q2
Sell
-900
Closed -$256K 425
2022
Q1
$256K Hold
900
﹤0.01% 479
2021
Q4
$339K Hold
900
﹤0.01% 458
2021
Q3
$371K Hold
900
﹤0.01% 434
2021
Q2
$333K Hold
900
﹤0.01% 444
2021
Q1
$261K Hold
900
﹤0.01% 461
2020
Q4
$225K Sell
900
-900
-50% -$214K ﹤0.01% 476
2020
Q3
$408K Hold
1,800
﹤0.01% 389
2020
Q2
$314K Hold
1,800
﹤0.01% 426
2020
Q1
$227K Buy
1,800
+100
+6% +$15K ﹤0.01% 403
2019
Q4
$260K Hold
1,700
﹤0.01% 455
2019
Q3
$225K Hold
1,700
﹤0.01% 476
2019
Q2
$241K Hold
1,700
﹤0.01% 478
2019
Q1
$247K Buy
+1,700
New +$223K ﹤0.01% 477

Other funds holding CRL

Fort Washington Investment Advisors's CRL Position: Q2 2026 in Review

Fort Washington Investment Advisors held its Charles River Laboratories (CRL) position steady in Q2 2026 at 1,300 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Fort Washington Investment Advisors first reported a position in CRL in Q1 2019 and has held it in 22 quarters since. The position peaked at $408K in Q3 2020. 105 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Fort Washington Investment Advisors held 1,300 shares of Charles River Laboratories worth $295K as of Q2 2026.
  • Fort Washington Investment Advisors left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #381 holding.
  • Fort Washington Investment Advisors first reported a position in Charles River Laboratories in Q1 2019 and has held it in 22 quarters since.
  • Fort Washington Investment Advisors's Charles River Laboratories position peaked at $408K in Q3 2020.
  • 105 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.